Why did a 38-year-old woman with neurofibromatosis type 1 (NF1) develop choroidal Yasunari nodules in both eyes? That's what Danish clinicians had to figure out when the patient presented for a ...

Housing instability, food insecurity and other factors related to social deprivation come with significantly greater risks ...

VANCOUVER -- Patients with proliferative diabetic retinopathy (PDR) had similar 5-year vision outcomes when treated with intravitreal ranibizumab (Lucentis) or panretinal photocoagulation (PRP), a ...

A recent study published in the Journal of Cataract & Refractive Surgery found that Yttrium Aluminum Garnet (YAG) laser ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio LAS VEGAS — Ranibizumab is noninferior to ...

Laser photocoagulation is a type of laser eye surgery. It is used to treat age-related macular degeneration (AMD) (1). AMD ...

The aim of this study was to determine the frequency of postoperative NVG and the risk factors for its development in PDR eyes after vitrectomy. Kaplan-Meier analysis revealed that 5.3% of ...

LAS VEGAS — Ranibizumab, a vascular endothelial growth-factor (VEGF) inhibitor that is part of the existing armamentarium for retina specialists, may be the first major treatment advance in 40 years ...

Injecting the corticosteroid triamcinolone into the eye may slow the progression of diabetic retinopathy, a complication of diabetes that can cause vision loss and blindness, according to a new study.

Anti-vascular endothelial growth factor (VEGF) therapy may be useful for patients with retinal nonperfusion, as the treatment does not exacerbate the nonperfusion, according to a study published in ...